Cancer Insight
Founded 2013 · 14 employees on LinkedIn · 1 known investors
Find your way into Cancer Insight
52 people in our graph share verified history with the Cancer Insight team — schools, employers, funds. One of them is your warm intro.
Hal Pazunlockedknows George Peoples · together at The Johns Hopkins University School of Medicine
×11knows the team · via The Johns Hopkins University School of Medicine
LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.
Founders & leadership
Cancer Insight was founded in 2013 by George Peoples.
GP
George PeoplesinFounderDr. George E. Peoples is a retired military surgical oncologist and founder of Cancer Insight, a clinical research organization specializing in oncology and immunotherapy that was rebranded as LumaBridge following a 2021 majority acquisition by Summit Partners and subsequently acquired by Avance Clinical in 2025. He previously served as Chief of Surgical Oncology at Walter Reed and Brooke Army Medical Centers and holds faculty positions at the Uniformed Services University of the Health Sciences and MD Anderson Cancer Center, with over 350 peer-reviewed publications on cancer immunotherapy.
Investors · 1
Competitors · 5
by search overlap
ADP5 shared keywordsADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally. The company serves as a comprehensive provider of HCM software and business outsourcing services with analytics and compliance expertise.
Bridgebio5 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Lumanity5 shared keywordsLumanity provides consulting services across strategy, evidence generation, stakeholder engagement, and technology and AI to support pharmaceutical and life sciences companies in bringing medicines to patients. It helps clients identify value inflection points to inform strategic decisions in drug development and commercialization.
Dynamically View VUVP's Portfolio4 shared keywordsConsider is a recruiting platform that helps talent teams source and manage candidate profiles, including a Chrome extension for adding LinkedIn profiles to talent pools in one click. It offers recruiting analytics, SSO, and two-way integrations with tools such as Greenhouse, Lever, and Salesforce.
Preqin4 shared keywordsPreqin provides a data and intelligence platform for investment teams, M&A professionals, and corporate development teams to source, evaluate, and value private company investments through integrated asset, fund, and performance data.
Companies competing with Cancer Insight for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cancer Insight do?
- LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.
- Who founded Cancer Insight?
- Cancer Insight was founded by George Peoples in 2013.
- Who are Cancer Insight's investors?
- Cancer Insight's investors include Summit Partners.